Shionogi & Co. Ltd. (SGIOF)
15.20
0.00 (0.00%)
At close: Apr 21, 2025, 8:00 PM
0.00% (1D)
| Bid | 15.01 |
| Market Cap | 12.93B |
| Revenue (ttm) | 423.36B |
| Net Income (ttm) | 150.1B |
| EPS (ttm) | 1.38 |
| PE Ratio (ttm) | 11.01 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 17.48 |
| Volume | 1,500 |
| Avg. Volume (20D) | 270 |
| Open | 15.20 |
| Previous Close | 15.20 |
| Day's Range | 15.20 - 15.20 |
| 52-Week Range | 12.21 - 45.50 |
| Beta | 0.15 |
About SGIOF
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment. It also develops Symproic for opioid-induced constipation treatment; S-120083 for Inflammatory pain; S-010887 for Neuropathic pain; S-1...
Sector Healthcare
IPO Date Feb 28, 2018
Employees 4,959
Stock Exchange PNK
Ticker Symbol SGIOF
Website https://www.shionogi.com
